Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Net Equity Issued and Repurchased (2010 - 2026)

Updated

Northwest Biotherapeutics (NWBO) posted Net Equity Issued and Repurchased of $104,000 for Q2 2026, down 98.6% from $7.32 million a year earlier and down 96.4% from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Northwest Biotherapeutics was $9.88 million, down 58.4% year-over-year; for FY2025, it was $19.32 million, up 35.9% from FY2024.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 6.8% (FY2020 to FY2025).
  • In prior years, Northwest Biotherapeutics' Net Equity Issued and Repurchased was $14.22 million in FY2024 (+6.7%), $13.33 million in FY2023 (-28.6%), $18.67 million in FY2022 (-6.7%) and $20 million in FY2021 (+43.7%).
  • The Q2 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased since Q3 2023.
  • On a year-over-year basis, Net Equity Issued and Repurchased has declined in each of the last four quarters, with growth averaging 51.8% over the last seven quarters.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q1 2022, with growth of 461.7%; the weakest was Q2 2026, with a decline of 98.6%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $2.9 million (Q1 2026), $2.02 million (Q4 2025) and $4.86 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 6.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 9.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - 104,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 104,000.00
Mar 31, 2026 2.90 Mn
Dec 31, 2025 2.02 Mn
Sep 30, 2025 4.86 Mn
Jun 30, 2025 7.32 Mn
Mar 31, 2025 5.12 Mn
Dec 31, 2024 4.21 Mn
Sep 30, 2024 7.11 Mn
Jun 30, 2024 1.59 Mn
Mar 31, 2024 1.31 Mn
Dec 31, 2023 11.73 Mn
Sep 30, 2023 32,000.00
Jun 30, 2023 -819,000.00
Mar 31, 2023 2.39 Mn
Dec 31, 2022 8.68 Mn
Sep 30, 2022 430,000.00
Jun 30, 2022 5.37 Mn
Mar 31, 2022 4.19 Mn
Dec 31, 2021 7.89 Mn
Sep 30, 2021 8.04 Mn
API Access

Northwest Biotherapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NWBO&period=max&api_key=YOUR_API_KEY